2015
DOI: 10.1681/asn.2014050481
|View full text |Cite
|
Sign up to set email alerts
|

IgD Heavy-Chain Deposition Disease

Abstract: Monoclonal Ig deposition disease (MIDD) is a rare complication of monoclonal gammopathy characterized by deposition of monoclonal Ig light chains and/or heavy chains along the glomerular and tubular basement membranes. Here, we describe a unique case of IgD deposition disease. IgD deposition is difficult to diagnose, because routine immunofluorescence does not detect IgD. A 77-year-old man presented with proteinuria and renal failure, and kidney biopsy analysis showed a nodular sclerosing GN with extensive foc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
21
0
4

Year Published

2016
2016
2019
2019

Publication Types

Select...
6
4

Relationship

2
8

Authors

Journals

citations
Cited by 34 publications
(25 citation statements)
references
References 34 publications
0
21
0
4
Order By: Relevance
“…LC-MS can also be useful in the diagnosis of MGRSassociated lesions other than immunoglobulin amyloidosis when immunofluorescence studies are not available or have negative findings. An example of the latter situation is IgD heavy-chain deposition disease, which is generally missed by immunofluorescence studies because an IgD antibody is not included in the routine immunofluorescence panel 110 .…”
Section: Renal Biopsy Evaluationmentioning
confidence: 99%
“…LC-MS can also be useful in the diagnosis of MGRSassociated lesions other than immunoglobulin amyloidosis when immunofluorescence studies are not available or have negative findings. An example of the latter situation is IgD heavy-chain deposition disease, which is generally missed by immunofluorescence studies because an IgD antibody is not included in the routine immunofluorescence panel 110 .…”
Section: Renal Biopsy Evaluationmentioning
confidence: 99%
“…The combination of LCMD and mass spectrometry identified proteins responsible for glomerular amyloid deposits 18,19 , defined targets of autoantibodies in glomerular immune complexes from membranous nephropathy and lupus nephritis patients 20-22 , identified a patient with IgD heavy-chain disease 23 , and determined the components of the complement cascade in patients with C3 glomerulonephritis 24 .…”
Section: Discussionmentioning
confidence: 99%
“…LMD/MS is useful in the setting of patients with unusual cases of MIDD where the MIg is truncated or is not tested for by routine IF studies. For example, HCDD comprising d-heavy chains can be diagnosed using LMD/ MS. 77 4. In some patients with MPGN associated with MIg, in whom the lesions are chronic or the deposits are masked, the MIg may be undetectable by routine IF.…”
Section: Confirmation Of Al/ah Lmd/msmentioning
confidence: 99%